Peter MacCallum Cancer Centre
Also known as: ANZUP and Peter MacCallum Cancer Centre | Centre for Biostatistics and Clinical Trials (BaCT) | Department of Medical Oncology,Peter MacCallum Cancer Centre,East Melbourne, Victoria, Australia | Peter MacCallum Cancer Center | Peter MacCallum Cancer Centre, Australia | Peter MacCallum Cancer Centre, East Melbourne, Victoria, AUSTRALIA | Peter MacCallum Cancer Centre, Melbourne, Australia | Peter MacCallum Cancer Centre, Melbourne, Australia. | Peter MacCallum Cancer Centre & Royal Melbourne Hospital | Peter MacCallum Cancer Institute | Peter MacCallum Cancer Research | Peter Mc Callum Cancer Centre, Melbourne, Australia | The Peter MacCallum Cancer Centre | TROG and Peter MacCallum Cancer Centre | Victorian Comprehensive Cancer Centre Peter Macallum hospital)
Highest phase reached
Phase 4
First clinical trial
May 1, 1999Last known activity
Dec 1, 2025
Timeline
1940s
- Apr 27, 1949
Peter MacCallum Cancer Centre— Founded
Drugs by trial phase (123 distinct, 105 trials)
Phase 4 (8 own, 0 via acquisition)
Phase 3 (26 own, 0 via acquisition)
Phase 2 (66 own, 0 via acquisition)
Phase 1 (17 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Studied for
- Bone Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Adenoid Cystic
- Carcinoma, Merkel Cell
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Carcinosarcoma
- Colonic Neoplasms
- Colorectal Neoplasms
- Esophageal Neoplasms
- Fallopian Tube Neoplasms
- Fatigue
- Gastrointestinal Stromal Tumors
- Head and Neck Neoplasms
- Hodgkin Disease
- Infertility
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Follicular
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Cutaneous
- Lymphoma, T-Cell, Peripheral
- Melanoma
- Mixed Tumor, Mullerian
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Plasma Cell
- Ovarian Neoplasms
- Parasomnias
- Polycythemia
- Polycythemia Vera
- Preleukemia
- Primary Myelofibrosis
- Prostatic Neoplasms
- Rectal Neoplasms
- Recurrence
- Sarcoma
- Sleep Wake Disorders
- Squamous Cell Carcinoma of Head and Neck
- Stomach Neoplasms
- Syndrome
- Thrombocythemia, Essential
- Thrombocytopenia
- Thrombocytosis
- Triple Negative Breast Neoplasms
- Urinary Bladder Neoplasms
- Uterine Cervical Neoplasms
- Virus Diseases
- Waldenstrom Macroglobulinemia
Recent trials (50)
- NCT07217938Lead sponsorPhase 2Dec 1, 2025
- NCT07215585OfficialPhase 3Nov 2, 2025
- NCT07090369Lead sponsorPhase 1Nov 1, 2025
- NCT06812715Lead sponsorPhase 2May 31, 2025
- NCT06414148OfficialPhase 2May 14, 2024
- NCT06414148Lead sponsorPhase 2May 14, 2024
- NCT06120491OfficialPhase 3Nov 21, 2023
- NCT06120491Overall official - principal investigatorPhase 3Nov 21, 2023
- NCT05983159CollaboratorPhase 2Sep 30, 2023
- NCT05864742Lead sponsorPhase 2Sep 7, 2023
- NCT05878288Overall official - principal investigatorPhase 2May 26, 2023
- NCT05878288Lead sponsorPhase 2May 26, 2023
- NCT05666700Overall official - principal investigatorPhase 1Feb 28, 2023
- NCT05666700Lead sponsorPhase 1Feb 28, 2023
- NCT05619913Overall official - principal investigatorPhase 2Dec 31, 2022
Details
- Founded
- Melbourne, AU Apr 27, 1949
- Last known activity
- Dec 1, 2025